Revance Therapeutics (RVNC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RVNC | LCTX | PEPG | ||
| Company | Revance Therapeutics | Lineage Cell Therapeutics Inc | Pepgen Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 3.65 | 1.7000 | 5.23 | ||
| High | 3.66 | 1.7350 | 5.58 | ||
| Low | 3.65 | 1.6500 | 5.20 | ||
| Latest | 3.65 | 1.6800 | 5.42 | ||
| Change | +0.01 | -0.0700 | +0.22 | ||
| % Change | +0.27% | -4.00% | +4.23% | ||
| Volume | 4,123,100 | 4,522,100 | 2,214,200 | ||
| 20-Day Average Volume | 2,900,350 | 1,427,840 | 811,355 | ||
| Previous Close | 3.64 | 1.7500 | 5.20 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.53 | 1.7185 | 5.61 | ||
| 20-Day Raw Stochastic | 89.36% | 44.00% | 23.08% | ||
| 20-Day Relative Strength | 52.71 | 48.22 | 52.87 | ||
| Weighted Alpha | -53.44 | +152.25 | -21.42 | ||
| Today's Opinion | 24% Sell | 40% Buy | 80% Buy | ||
| Previous Opinion | 24% Sell | 72% Buy | 80% Buy | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.27% since 01/29/25 | +1.20% since 12/12/25 | -4.24% since 12/12/25 | ||
| Low | 3.62 on 01/30/25 | 1.6500 on 12/19/25 | 5.07 on 12/18/25 | ||
| High | 3.66 on 02/05/25 | 1.8200 on 12/18/25 | 5.72 on 12/15/25 | ||
| 1-Month | |||||
| %Chg | +18.12% since 01/03/25 | -1.75% since 11/19/25 | -1.99% since 11/19/25 | ||
| Low | 3.23 on 01/10/25 | 1.5700 on 12/03/25 | 5.03 on 12/08/25 | ||
| High | 3.70 on 01/17/25 | 1.8200 on 12/18/25 | 6.72 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | -37.50% since 11/05/24 | +9.80% since 09/19/25 | +188.30% since 09/19/25 | ||
| Low | 3.01 on 12/09/24 | 1.4700 on 09/22/25 | 1.86 on 09/22/25 | ||
| High | 5.97 on 11/06/24 | 2.0900 on 11/03/25 | 6.72 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | +19.28% since 08/05/24 | +83.59% since 06/18/25 | +268.71% since 06/18/25 | ||
| Low | 2.80 on 08/07/24 | 0.8500 on 07/01/25 | 1.01 on 08/12/25 | ||
| High | 6.65 on 08/19/24 | 2.0900 on 11/03/25 | 6.72 on 11/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 381,023 | 386,951 | 372,614 | ||
| Shares Outstanding, K | 104,390 | 230,328 | 68,748 | ||
| Annual Sales | 234,040,000 | 9,500,000 | 0 | ||
| Annual Net Income | -323,990,000 | -18,610,000 | -89,980,000 | ||
| Last Quarter Sales | 59,880,000 | 3,680,000 | 0 | ||
| Last Quarter Net Income | -38,120,000 | -29,780,000 | -18,030,000 | ||
| 60-Month Beta | 0.90 | 1.78 | 1.91 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/07/24 | -0.13 on 11/06/25 | -0.52 on 11/12/25 | ||
| Latest Earnings Date | 02/26/25 | 03/09/26 | 02/23/26 | ||
| Most Recent Dividend | N/A | 0.080 on 12/15/03 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||